Connect with us

Business

C-Care to raise Rs50M from doctors to fund business plans

Published

on

C-care facility in Tamarin. Photo source: Defi Media

C-Care (Mauritius) Ltd, a Mauritian private healthcare group, owning and operating the two main private healthcare facilities in Mauritius, needs cash.

It is looking to raise new capital of up to Rs50M by way of private placement to “Eligible Practicing Doctors and Eligible Senior Management of C-Care.”

The announcement was published on the website of the Stock Exchange of Mauritius.

It intends to issue a maximum issue of 500 Redeemable Preference Shares at an issue price of Rs100,000 per Redeemable Preference Share.

“Such scheme has been devised to finance innovation and expansion in C-Care in line with its current strategy and to allow doctors and senior management to participate in the performance of the Company, alongside the existing ordinary shareholders,” it said.

C-Care operates Clinique Darné and Wellkin Hospital. C-Care also owns and manages C-Care Clinic and C-Lab.

The Group created in 2008 and formerly known as The Medical and Surgical Centre Limited is part of the CIEL Healthcare network whose majority shareholder is CIEL, a Mauritian diversified Investment Group.

Bookmark(0)

No account yet? Register

Spread the News
The information and opinions expressed in our published works are those of authors/sources believed to be reliable. NewsMoris makes no representations as to accuracy, completeness, suitability, or validity of any information expressed.
Click to comment

Leave a Reply

Your email address will not be published.

The information and opinions expressed in our published works are those of authors/sources believed to be reliable. NewsMoris makes no representations as to accuracy, completeness, suitability, or validity of any information expressed.

Can you support?

Dear Reader,

NewsMoris is a media service that is dependent on support from its readers in the form of subscriptions.

As a startup that was born in and faring through challenging times like these, we need your support now more than ever.

Subscribing for as little as USD10/month is the best way you can support our efforts.

Thank you.